Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.08 USD | +1.82% | +2.54% | +6.55% |
04-30 | Transcript : Welltower Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating | MT |
Evolution of the average Target Price on Welltower Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Welltower Inc.
BNP Paribas Exane | |
Scotiabank | |
KeyBanc Capital Markets | |
Mizuho Securities | |
JPMorgan Chase | |
RBC Capital Markets | |
Evercore ISI | |
Wells Fargo Securities | |
Raymond James | |
Wedbush | |
Morgan Stanley | |
Barclays | |
Deutsche Bank Securities | |
Citigroup | |
Credit Suisse | |
Baird | |
Berenberg Bank | |
SMBC Nikko | |
Jefferies & Co. | |
BMO Capital | |
Wolfe Research | |
Capital One Securities | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- WELL Stock
- Consensus Welltower Inc.